Details of Disease
General Information of Disease (ID: DISTGKN8)
| Disease Name | ALG9-congenital disorder of glycosylation | |||||
|---|---|---|---|---|---|---|
| Synonyms | 
                                         
                        congenital disorder of glycosylation type IL; CDG IL; carbohydrate deficient glycoprotein syndrome type IL; ALG9-CDG (CDG-IL); congenital disorder of glycosylation, type IL; CDG 1L; mannosyltransferase 7-9 deficiency; carbohydrate deficient glycoprotein syndrome type 1L; CDG1L; CDG syndrome type IL; CDG-IL; congenital disorder of glycosylation type 1L; ALG9-congenital disorder of glycosylation; ALG9-CDG
                        
                     
                                     | 
            |||||
| Definition | 
                                         
                        A form of congenital disorders of N-linked glycosylation characterized by progressive microcephaly, hypotonia, developmental delay, drug-resistant infantile epilepsy, and hepatomegaly. Additional features that may be observed include failure to thrive, pericardial effusion, renal cysts, skeletal dysplasia, facial dysmorphism (frontal bossing, hypertelorism, depressed nasal bridge, low-seated ears, large mouth) and hydrops fetalis. The disease is caused by loss-of-function mutations in the gene ALG9 (11q23).
                        
                     
                                     | 
            |||||
| Disease Hierarchy | ||||||
| Disease Identifiers | ||||||
Molecular Interaction Atlas (MIA) of This Disease
| Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 
                     This Disease Is Related to 2 DOT Molecule(s) 
                                                
  | 
            ||||||||||||||||||||||||||||||
References
